These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 15062764

  • 1. The ADVIA Centaur immunoassay system--designed for infectious disease testing.
    Okrongly D.
    J Clin Virol; 2004 Apr; 30 Suppl 1():S19-22. PubMed ID: 15062764
    [Abstract] [Full Text] [Related]

  • 2. The ADVIA Centaur infectious disease assays: a technical review.
    Dwyer R.
    J Clin Virol; 2004 Apr; 30 Suppl 1():S1-5. PubMed ID: 15062760
    [Abstract] [Full Text] [Related]

  • 3. An update on laboratory productivity with infectious disease assays on the Bayer ADVIA Centaur Immunoassay System.
    Dati F.
    Clin Lab; 2004 Apr; 50(1-2):53-61. PubMed ID: 15000221
    [Abstract] [Full Text] [Related]

  • 4. Experience with the IVDD performance evaluations of the ADVIA Centaur infectious disease assays.
    van Helden J, Denoyel GA.
    J Clin Virol; 2004 Apr; 30 Suppl 1():S16-8. PubMed ID: 15062763
    [No Abstract] [Full Text] [Related]

  • 5. Performance of hepatitis B assays on the Bayer ADVIA Centaur Immunoassay System.
    van Helden J, Denoyel G, Karwowska S, Reamer R, Schmalz J, Wright T, Preisel-Simmons B.
    Clin Lab; 2004 Apr; 50(1-2):63-73. PubMed ID: 15000222
    [Abstract] [Full Text] [Related]

  • 6. Comparison of the ADVIA Centaur and Abbott AxSYM immunoassay systems for a routine diagnostic virology laboratory.
    Taylor P, Pickard G, Gammie A, Atkins M.
    J Clin Virol; 2004 Apr; 30 Suppl 1():S11-5. PubMed ID: 15062762
    [Abstract] [Full Text] [Related]

  • 7. European performance evaluations of the ADVIA Centaur infectious disease assays: requirements for performance evaluation according to the European directive on in vitro diagnostics.
    Dati F, Denoyel G, van Helden J.
    J Clin Virol; 2004 Apr; 30 Suppl 1():S6-10. PubMed ID: 15062761
    [Abstract] [Full Text] [Related]

  • 8. Performance of a new hepatitis C assay on the Bayer ADVIA Centaur Immunoassay System.
    Denoyel G, van Helden J, Bauer R, Preisel-Simmons B.
    Clin Lab; 2004 Apr; 50(1-2):75-82. PubMed ID: 15000223
    [Abstract] [Full Text] [Related]

  • 9. Performance of a new HIV 1/O/2 assay on the Bayer ADVIA Centaur immunoassay system.
    van Helden J, Denoyel G, Freeman J, Preisel-Simmons B.
    Clin Lab; 2004 Apr; 50(1-2):83-90. PubMed ID: 15000224
    [Abstract] [Full Text] [Related]

  • 10. Performance evaluation of the ADVIA Centaur anti-HBe and HBeAg assays.
    van Helden J, Cornely C, Dati F, Levy HR, Bal T, Seeger M, Wright T, Baker L.
    J Clin Virol; 2008 Oct; 43(2):169-75. PubMed ID: 18635392
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of two chemiluminescent immunoassays of ADVIA Centaur for hepatitis B serology markers.
    Chen D, Kaplan L, Liu Q.
    Clin Chim Acta; 2005 May; 355(1-2):41-5. PubMed ID: 15820476
    [Abstract] [Full Text] [Related]

  • 12. Comparison of the technical and clinical performance of the Elecsys HBsAg II assay with the Architect, AxSym, and Advia Centaur HBsAg screening assays.
    Louisirirotchanakul S, Khupulsup K, Akraekthalin S, Chan KP, Saw S, Aw TC, Cho DH, Shin MG, Lim J.
    J Med Virol; 2010 May; 82(5):755-62. PubMed ID: 20336717
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of a new molecular assay for detection of human immunodeficiency virus type 1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA.
    McCormick MK, Dockter J, Linnen JM, Kolk D, Wu Y, Giachetti C.
    J Clin Virol; 2006 Jul; 36(3):166-76. PubMed ID: 16427802
    [Abstract] [Full Text] [Related]

  • 14. Laboratory evaluation of the UniCel DxI 800 analyser (Beckman Coulter) for detecting HBV and HCV serological markers.
    Miedouge M, Legrand-Abravanel F, Lalanne C, Saune K, Izopet J.
    J Clin Virol; 2009 Feb; 44(2):134-7. PubMed ID: 19110466
    [Abstract] [Full Text] [Related]

  • 15. Performance evaluation of a specific IgE assay developed for the ADVIA centaur immunoassay system.
    Petersen AB, Gudmann P, Milvang-Grønager P, Mørkeberg R, Bøgestrand S, Linneberg A, Johansen N.
    Clin Biochem; 2004 Oct; 37(10):882-92. PubMed ID: 15369719
    [Abstract] [Full Text] [Related]

  • 16. [Short communication: comparison of two different assays for the investigation of HBsAG, anti-HCV and anti-HIV in blood donors].
    Cavdar E, Kuştimur S, Doğruman Al F.
    Mikrobiyol Bul; 2006 Oct; 40(4):363-7. PubMed ID: 17205694
    [Abstract] [Full Text] [Related]

  • 17. Multicenter evaluation of the Bayer ADVIA Centaur HIV 1/O/2 enhanced (EHIV) assay.
    Schappert J, Wians FH, Schiff E, Smalley D, Gambardella R, Lee WM, Wu J, Keiser P, Peterson D, De Medina M, Baker L, Preisel-Simmons B.
    Clin Chim Acta; 2006 Oct; 372(1-2):158-66. PubMed ID: 16769045
    [Abstract] [Full Text] [Related]

  • 18. Comparison of the automated AxSYM and ADVIA centaur immunoassays for homocysteine determination.
    Haltmayer M, Mueller T, Gegenhuber A, Poelz W.
    Clin Lab; 2004 Oct; 50(3-4):175-80. PubMed ID: 15074472
    [Abstract] [Full Text] [Related]

  • 19. The analytic sensitivity and mutant detection capability of six hepatitis B surface antigen assays.
    La'ulu SL, Roberts WL.
    Am J Clin Pathol; 2006 May; 125(5):748-51. PubMed ID: 16707377
    [Abstract] [Full Text] [Related]

  • 20. Performance characteristics of the ARCHITECT anti-HCV assay.
    Jonas G, Pelzer C, Beckert C, Hausmann M, Kapprell HP.
    J Clin Virol; 2005 Oct; 34(2):97-103. PubMed ID: 16122974
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.